Bimini Health Tech is dedicated to transforming the human experience, driven by passion to develop a diverse portfolio of novel regenerative technologies and therapeutics that allow people to live better, longer lives.
Bimini products are designed to avoid
the need for frequent re-treatment.
The use of autologous stromal vascular fraction (SVF)
in preclinical and clinical studies has been shown to be well tolerated.
Thousands of patients have been treated with fatty tissue and SVF in numerous worldwide
clinical trials.
Bimini products eliminate the requirement for tissues and cells to be shipped to off-site facilities.
Tissue can be harvested and processed on-site for convenient care.
Since 2013, we have been developing innovative products to provide premium care options to consumers and physicians alike.
Jérémy Magalon a obtenu son doctorat en pharmacie à l'université d'Aix-Marseille en 2013 après avoir effectué son stage de biologie médicale avec une spécialisation en thérapie cellulaire. Il est titulaire d'un diplôme universitaire en médecine régénérative et d'un master en biologie tissulaire, cellulaire et génétique. Pendant son stage, il a travaillé principalement sur la thérapie PRP autologue et ses autres domaines d'expertise sont la fraction vasculaire stromale autologue dérivée du tissu adipeux et la greffe de tissu adipeux. En 2014, il devient praticien hospitalier à l'hôpital Necker (Paris) dans le service de biothérapie où il participe à des essais cliniques utilisant la thérapie génique pour soigner des patients atteints d'hémoglobinopathie sévère. Il a obtenu son diplôme de docteur en sciences en 2018, intitulé "Développement d'un médicament thérapeutique innovant utilisant la fraction vasculaire stromale du tissu adipeux autologue dans la sclérose systémique : De la caractérisation biologique à l'identification de biomarqueurs potentiels d'efficacité". Il est actuellement maître de conférences et praticien hospitalier à l'Université d'Aix-Marseille (Faculté de pharmacie) et au Centre Hospitalier Universitaire de La Conception (Département de thérapie cellulaire).
Depuis octobre 2017, il coordonne l'activité d'injection de plasma riche en plaquettes du Centre Hospitalier Universitaire de Marseille, où la PRP est utilisée dans divers domaines médicaux. Il est l'auteur de plus de 50 articles et 2 chapitres de livres en médecine régénérative, et a été conférencier dans plus de 30 conférences et cours nationaux et internationaux.
---------------
Jérémy Magalon received his PharmD at the University of Aix-Marseille in 2013 after completing his internship in medical biology with a specialization in cell therapy. He holds a university degree in regenerative medicine and a master's degree in tissue, cell and gene biology. During his internship, he mainly works on autologous PRP therapy and his other areas of expertise are autologous stromal vascular fraction derived from adipose tissue and adipose tissue graft. In 2014, he became a hospital practitioner at the Necker Hospital (Paris) in the biotherapy department where he was involved in clinical trials using gene therapy to cure patients with severe hemoglobinopathy. He graduated as a doctor of science in 2018 entitled "Development of an Innovative Therapy Drug Using the Stromal Vascular Fraction of Autologous Adipose Tissue in Systemic Sclerosis: From Biological Characterization to Identification of Potential Biomarkers of Efficacy" . He is currently Senior Lecturer and Hospital Practitioner at the University of Aix-Marseille (Faculty of Pharmacy) and at the University Hospital of La Conception (Department of Cell Therapy).
Since October 2017, he coordinates the platelet - rich plasma injection activity of the University Hospital of Marseille, where PRP is used in various medical fields. He is the author of more than 50 articles and 2 chapters of books in Regenerative Medicine, and has been a speaker at more than 30 national and international conferences and courses.
Jérémy Magalon a obtenu son doctorat en pharmacie à l'université d'Aix-Marseille en 2013 après avoir effectué son stage de biologie médicale avec une spécialisation en thérapie cellulaire. Il est titulaire d'un diplôme universitaire en médecine régénérative et d'un master en biologie tissulaire, cellulaire et génétique. Pendant son stage, il a travaillé principalement sur la thérapie PRP autologue et ses autres domaines d'expertise sont la fraction vasculaire stromale autologue dérivée du tissu adipeux et la greffe de tissu adipeux. En 2014, il devient praticien hospitalier à l'hôpital Necker (Paris) dans le service de biothérapie où il participe à des essais cliniques utilisant la thérapie génique pour soigner des patients atteints d'hémoglobinopathie sévère. Il a obtenu son diplôme de docteur en sciences en 2018, intitulé "Développement d'un médicament thérapeutique innovant utilisant la fraction vasculaire stromale du tissu adipeux autologue dans la sclérose systémique : De la caractérisation biologique à l'identification de biomarqueurs potentiels d'efficacité". Il est actuellement maître de conférences et praticien hospitalier à l'Université d'Aix-Marseille (Faculté de pharmacie) et au Centre Hospitalier Universitaire de La Conception (Département de thérapie cellulaire).
Depuis octobre 2017, il coordonne l'activité d'injection de plasma riche en plaquettes du Centre Hospitalier Universitaire de Marseille, où la PRP est utilisée dans divers domaines médicaux. Il est l'auteur de plus de 50 articles et 2 chapitres de livres en médecine régénérative, et a été conférencier dans plus de 30 conférences et cours nationaux et internationaux.
---------------
Jérémy Magalon received his PharmD at the University of Aix-Marseille in 2013 after completing his internship in medical biology with a specialization in cell therapy. He holds a university degree in regenerative medicine and a master's degree in tissue, cell and gene biology. During his internship, he mainly works on autologous PRP therapy and his other areas of expertise are autologous stromal vascular fraction derived from adipose tissue and adipose tissue graft. In 2014, he became a hospital practitioner at the Necker Hospital (Paris) in the biotherapy department where he was involved in clinical trials using gene therapy to cure patients with severe hemoglobinopathy. He graduated as a doctor of science in 2018 entitled "Development of an Innovative Therapy Drug Using the Stromal Vascular Fraction of Autologous Adipose Tissue in Systemic Sclerosis: From Biological Characterization to Identification of Potential Biomarkers of Efficacy" . He is currently Senior Lecturer and Hospital Practitioner at the University of Aix-Marseille (Faculty of Pharmacy) and at the University Hospital of La Conception (Department of Cell Therapy).
Since October 2017, he coordinates the platelet - rich plasma injection activity of the University Hospital of Marseille, where PRP is used in various medical fields. He is the author of more than 50 articles and 2 chapters of books in Regenerative Medicine, and has been a speaker at more than 30 national and international conferences and courses.
Aesthetic physician, Medical Director at Forever Institut Geneva (Switzerland), specialist in Aesthetic Gynecology, specialist in Regenerative Medicine (PRP, Microfat, Nonfat, Stemcells...), specialist in Internal medicine.
Physician trainer in HA & Botulinum Toxin for Allergan, Physician trainer Ulthera and Cellfina for Merz.
Medical speaker at international courses and congress.
Senior lecturer in the faculty Henri Mondor (DUMEG) Paris University Diploma of injection technique and fillers (DUTIC) Paris (France), University Certificate of Aesthetic and Restorative Gynecology (CUMEG) Paris (France), University diploma of mesotherapy (DIU Mesotherapy) Paris (France), University Certificate of Aesthetic Medicine Paris (France)
French Aesthetic Plastic surgeon, in private practice since 1994, General Secretary since 2015 and Former President (2014) of SOFCEP (French Aesthetic Plastic Surgeons Society), Member of ISAPS BoD (International Society of Aesth Plast Surgeons), Secretary of E(S)APS (European Ass Aesth Plast Surgeon), Chairman of intnl committee of ASAPS (American Soc Aesth Plast Surg), ASPS member. I live and work in Tours, in the heart of the Loire Valley, famous for its castles and wineries.
Dr. Steven R. Cohen and his team specialize in facelift surgery, fat grafting, rhinoplasty, chin augmentation, facial implants, breast augmentation, tummy tuck, liposuction and a wide variety of non-surgical options. Dr. Cohen's main interest is facelift surgery combined with fat grafting, as well as regenerative surgical approaches for breast and body contouring. His newer techniques of Injectable Tissue Replacement and Regeneration®, nano fat grafting, composite fat grafting and pre-periosteal fat grafting are unique in the field. Dr. Cohen was one of the first in the US to embrace non-surgical care and has developed the FACES+ Continuum of Care, which integrates preventative and maintenance care with non-surgical and surgical treatment. Dr. Cohen is happy to share his unique use of lasers, energy-based devices (Ultherapy, ThermiTight, Thermi250, ThermiVa and ThermiDry), microneedling, Instalift sutures and synthetic fillers. FACES+ has developed a variety of "ThermiFusion" procedures that act in synergy to provide better non-surgical outcomes.
Patient care is completely customized for the condition of the patient. Dr. Cohen's business principles are built around the most important component of plastic surgical practice: the patient experience. Dr. Cohen is an internationally recognized plastic surgeon, inventor, author and artist. Dr. Cohen has been selected as one of the Top Plastic Surgeons in America, by US News and World Report, Castle Connolly and Best Doctors, Inc. He has been recognized by his peers as one of San Diego’s Physicians of Exceptional Excellence in the field of Plastic Surgery 9 out of the last 12 years. Fresh Start Surgical Gifts has bestowed awards for his work with children and adults with severe craniofacial disorders. Dr. Cohen has donated over $500,000 dollars of surgical care over the past 15 years of his involvement and was responsible for the addition of the Fresh Start Craniofacial Center at Rady Children's Hospital in San Diego. He was chosen multiple times as Teacher of the Year by University of California-San Diego, Division of Plastic Surgery.
Participants in the FACES+ mentoring program are offered discounted marketing programs to help launch their newly acquired skills. In mentoring other surgeons and practitioners around the world, Dr. Cohen generously shares his artistic eye, technical advancements and keen business instincts.
Renowned Dr. Olivier Amar is a pioneering Consultant Plastic, Reconstructive & Aesthetic Surgeon, based in Central London.
He is a pioneering Consultant Plastic, Reconstructive & Aesthetic Surgeon who is based in central London. From a family of renowned French surgeons, his expertise is in facial rejuvenation using the innovative FAMI technique of tissue and stem cell transfer to the face; he also specialises in body contouring and breast enhancement. He believes in the art of subtlety – his objective is always to make a fine-drawn distinction tailored to the individual.
Surgeon specialized in Plastic, Reconstructive and Aesthetic Surgery
Reference point for Genital Reconstructive Surgery and Regenerative Surgery in the Plastic Surgery UnitReference point for Breast reconstruction in the Breast Unit
-------------------
Senior Surgeon of the Plastic and Breast Surgery Division at IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico, Milan, Italy
Visiting professor at the University of Milan (Postgraduate School of Plastic Surgery – prof. M. Klinger - and, earlier, Postgraduate School of Gynecology and Obstetrics – prof. Fedele)
Lecturer at the postgraduate Master course of Morphodynamic Aesthetic Surgery, University of Milan.
Lecturer at the “Agorà” High School of Esthetic Medicine of Milan.
